AUSTIN, Texas, July 29, 2016 /PRNewswire/ -- LifeLine Software, Inc., a worldwide leader in dosimetric quality assurance tools, and Radyalis LLC, a pioneer in advanced radiotherapy software, will be demonstrating the next generation of Monte Carlo quality assurance solutions at the 2016 AAPM Annual Meeting in Washington, D.C.
This joint collaboration allows LifeLine Software to bring to market industry changing 3D dose volume independent dosimetric verification products which utilize Radyalis' revolutionary Monte Carlo dose calculation engine for photons and electrons. Through fundamental advances in large-scale optimization and high-performance computing, LifeLine Software offerings make practical today the significant advantage of Monte Carlo accuracy for clinical usage.
In contrast to approximate analytic methods, Monte Carlo is widely recognized as the gold standard dose calculation method. Monte Carlo precisely models all relevant particle physics and materials including machine head and beam-limiting devices such as jaws, MLCs, and wedges. The most challenging clinical cases and complex structures are analyzed with the highest accuracy and confidence including heterogeneous head, neck, and lung regions, soft tissue, bony structures, and metal implants.
Flexible deployment options allow users to combine the precise accuracy of a Monte Carlo dose calculation algorithm with the levels of speed and productivity that allow busy radiation departments to meet their workflow needs. LifeLine Software offers unparalleled quality assurance accuracy and performance on current generation desktop and server platforms. A GPU is not required or necessary.
"We are excited to be demonstrating our world-class quality assurance software benefiting potentially millions of cancer patients worldwide at this year's AAPM meeting in Washington, D.C. This effort represents our hard work and commitment to our customers to bring the best tools to market with accuracy and speed that has been unimaginable until now. Our goal is to receive FDA clearance before the end of 2016. We will immediately market RadCalc® 3DMC to all of our non-U.S. markets after beta testing and regulatory requirements are met," said LifeLine Software's Co-Founder and President, Jim Dube.
The flagship demonstration at AAPM is the first of two new software products both companies are collaborating on to provide more advanced modalities and capabilities for radiotherapy treatment providers. Demonstrations can be booked directly at the LifeLine Software booth #4063.
LifeLine Software's CEO and Co-Founder Craig Laughton said, "At LifeLine Software, we have always strived to meet and exceed our customers' expectations and to listen to their needs. With the increasing complexity of treatment delivery, the demand for sophisticated quality assurance tools has grown. This demonstration represents our hard work and commitment to our customers to bring the best 3D dose validation tools to the market. We believe the Monte Carlo dose calculation technology provided by Radyalis will not only meet our customers' needs but exceed their expectations."
About LifeLine Software, Inc.
Founded in 1999 by Craig Laughton (CEO) and James Dube (President), Lifeline Software Inc. is a privately held software company headquartered in Tyler, Texas servicing over 2,100 radiation oncology centers worldwide. RadCalc® was developed to provide the most comprehensive QA software program FDA 510(k) cleared to perform independent dosimetric validation calculations including 2D/3D, IMRT, Compensator IMRT, VMAT, 3D Dose Volume-Brachytherapy, Superficial, CyberKnife, Diode, and EDW support.
Press Contact LifeLine Software, Inc.
LifeLine Software, Inc.
+1 866.592.1343 ext. 8
For more information, visit http://www.lifelinesoftware.com
About Radyalis LLC
Radyalis LLC develops and markets leadership software for radiotherapy applications that enables next-generation treatment planning and patient workflow. Based in Austin, Texas, the Radyalis team collectively brings 60+ years of related research and development experience to the particle therapy arena with focus on ultra-fast and accurate simulation and analysis methods. Radyalis has research collaborations with premier oncology research hospitals and is committed to fundamentally impacting the accuracy, productivity, and cost of treatment planning through the increased use of software automation.
Press Contact Radyalis LLC
For more information, visit http://radyalis.com
SOURCE LifeLine Software, Inc.